A highly-catalytic hydrogel modified biosensor for wearable and non-invasive glucose monitoring via reverse iontophoresis
Biosensors and Bioelectronics · 2026-11 · 312 · 119071
DOI: 10.1016/j.bios.2026.119071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026-11. Verfasst von Wangwang Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Precision Measurement Technology and Instruments, Tianjin University, Tianjin, 300072, China. Hauptthemen laut MEDLINE: Biosensing Techniques, Wearable Electronic Devices, Hydrogels, Iontophoresis. Die Arbeit nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Reverse iontophoresis (RI)-based continuous glucose monitoring (CGM) is promising for wearable diabetes management; however, its clinical translation remains limited by skin irritation associated with current operation, and the challenge of accurately quantifying low-concentration glucose. Here, we present a zwitterionic enzymatic hydrogel for wearable RI-based CGM. The hydrogel provides excellent skin affinity, enabling operation under low current density conditions to alleviate irritation, while its high catalytic activity accounts for the reduced glucose flux by the low current density and ensures detection of low-concentration glucose. The highly-catalytic hydrogel is modified onto flexible electrodes to construct a glucose sensor, making high sensitivity (437.03 nA mM-1), low detection limit (0.396 μM), and prolonged operational lifetime (69.42% retention after 30 days). The sensor is integrated with two RI electrodes to produce a glucose biosensor for wearable and non-invasive CGM. In vitro evaluation demonstrates accurate prediction of simulated subcutaneous glucose levels with a high correlation (R2 = 0.968). In vivo studies in both healthy subjects and patients with diabetes further confirm the capability of the proposed biosensor in practice, showing good agreement with the blood glucose and no observable skin erythema or irritation. Clarke error grid analysis shows that 97.5% of data fall within zones A and B, with a mean absolute relative difference (MARD) of 15.41% for healthy subjects and 16.43% for patients with diabetes. The biosensor also achieves a 20/20% agreement rate of 73.75%. This work provides a broadly applicable method and platform for wearable and non-invasive biosensing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Precision Measurement Technology and Instruments, Tianjin University, Tianjin, 300072, China.
- NHC Key Lab of Hormones and Development and Tianjin Key Lab of Metabolic Diseases, Tianjin Medical University Chu Hsien-I Memorial Hospital & Institute of Endocrinology, Tianjin, 300134, China.
- State Key Laboratory of Precision Measurement Technology and Instruments, Tianjin University, Tianjin, 300072, China. Electronic address: puzhihua@tju.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhu, W., Li, C., Li, W., Ma, Y., Zhang, X., Zheng, H., Li, M., Song, Z., Li, D., & Pu, Z. (2026). A highly-catalytic hydrogel modified biosensor for wearable and non-invasive glucose monitoring via reverse iontophoresis. Biosensors and Bioelectronics, 312, 119071. https://doi.org/10.1016/j.bios.2026.119071
Vancouver
Zhu W, Li C, Li W, Ma Y, Zhang X, Zheng H, et al. A highly-catalytic hydrogel modified biosensor for wearable and non-invasive glucose monitoring via reverse iontophoresis. Biosensors and Bioelectronics. 2026;312:119071. doi:10.1016/j.bios.2026.119071
BibTeX
@article{Zhu2026,
author = {Zhu, Wangwang and Li, Chengcheng and Li, Wenjun and Ma, Yuxiao and Zhang, Xingguo and Zheng, Hao and Li, Mingzhen and Song, Zhenqiang and Li, Dachao and Pu, Zhihua},
title = {A highly-catalytic hydrogel modified biosensor for wearable and non-invasive glucose monitoring via reverse iontophoresis},
journal = {Biosensors and Bioelectronics},
year = {2026},
volume = {312},
pages = {119071},
doi = {10.1016/j.bios.2026.119071}
}
EUVIMED